How Long for Botox to Work: Forehead in Days, Migraine in Cycles

There is no universal onset day, and the prescribing information says so in numbers. The BOTOX Cosmetic label states that chemical denervation of the injected muscle typically begins one to two days after injection and increases in intensity through the first week; its trials judged the result at Day 30 for frown lines, crow's feet and forehead lines, and at Day 14 for platysma bands. Therapeutic onabotulinumtoxinA runs on another clock: the BOTOX label gives initial effect within three days for blepharospasm, improvement beginning within two weeks and peaking near six weeks for cervical dystonia, and chronic migraine trials whose primary endpoint fell at week 24, across cycles repeated every 12 weeks. Watching a forehead, expect movement in days and a verdict at about a month. Waiting on migraine, the unit of time is the cycle.

Which Botox are you actually waiting on?

BOTOX Cosmetic and therapeutic BOTOX are the same molecule, onabotulinumtoxinA, carrying two separate labels. The cosmetic label lists four approved uses in adults: moderate to severe glabellar lines (corrugator and procerus), lateral canthal lines (orbicularis oculi), forehead lines (frontalis), and platysma bands, which the FDA added in October 2024.

A lip flip is not on that list. Neither is masseter slimming. Off-label injection is legal and common, and it means no agency has reviewed an onset curve for that muscle. There is no labeled date to count toward, and anyone quoting you one is quoting a different indication.

I spent nine years reading numbers stamped inside shoes, mostly children's, mostly on Saturdays. The number is a length. The fit is mostly a width, and the box never prints it. People argued with me about length all day and almost never asked about the dimension that decided whether the shoe worked. Your appointment card names a brand, and the brand is not the variable.

The first 72 hours, and what they do not settle

The BOTOX Cosmetic label, in the glabellar administration section, puts it plainly: the initial doses typically induce chemical denervation of the injected muscles one to two days after injection, increasing in intensity during the first week. That is the whole of the label's commitment on early onset. It describes a process starting, not a result arriving.

What you see in that window is local. Small bumps at the injection points that flatten within an hour, pinkness, sometimes a bruise.

What you cannot see yet is your result. Denervation increasing through the first week means the muscle you are testing on day four is partway along, and the two sides of your face are not obliged to arrive together.

When the trials actually looked

This is where the two-week rule comes from, and where it leaks.

In the glabellar line trials, the co-primary endpoints were the investigator's rating of line severity at maximum frown and the subject's own global assessment of change, both at Day 30. At that point 80% of the 405 subjects treated with BOTOX Cosmetic were rated responders by the investigator, against 3% of 132 on placebo; by the subjects' own assessment, 89% against 7%. Lateral canthal lines and forehead lines also used Day 30 as the primary timepoint.

Platysma bands did not. The two phase 3 trials behind the 2024 neck approval set their primary timepoint at Day 14, where 32% and 31% of treated subjects met the endpoint against 2% and 0% on placebo.

So the only cosmetic indication in this product assessed at fourteen days is the one in your neck. Everything above the eyebrows was judged at thirty.

The strongest argument against what I am saying is fair, and I will grant it first. Clinics that say "you'll see it in three to five days, judge it at two weeks" are not making that up. The label does describe denervation starting at one to two days, and the one controlled trial on this question found visible glabellar change by day three. Two weeks sits past peak onset for most upper-face work, it stops people panicking on day four, and it stops them buying a touch-up on day six. It is a defensible habit.

What it cannot do is act as biology. A rule of thumb built from cosmetic upper-face practice does not transfer to a neck endpoint measured at fourteen days, a dystonia endpoint at six weeks, or a migraine endpoint at twenty-four. The two-week rule is a boundary. It was never a schedule.

One more figure from the same label: duration of effect for glabellar lines is approximately three to four months. The label states that for glabellar lines. It gives no duration figure for forehead lines, lateral canthal lines or platysma bands. If you were promised four months on your forehead, that number was borrowed from your frown lines.

The other clock: muscle spasm and migraine

| Indication (per label) | Stated early effect | Stated peak or assessment point | Stated repeat interval | |---|---|---|---| | Glabellar, forehead, lateral canthal lines (BOTOX Cosmetic) | Denervation at one to two days, rising through week one | Trials judged at Day 30 | Not evaluated more often than every 3 months | | Platysma bands (BOTOX Cosmetic) | Same statement | Trials judged at Day 14 | Not evaluated more often than every 3 months | | Blepharospasm (BOTOX) | Initial effect generally within three days | Peak at one to two weeks | — | | Cervical dystonia (BOTOX) | Improvement generally begins within two weeks | Maximum benefit at approximately six weeks | Generally no sooner than 12 weeks | | Upper and lower limb spasticity (BOTOX) | — | — | Generally no sooner than 12 weeks | | Chronic migraine (BOTOX) | — | Week 24, PREEMPT primary endpoint | Every 12 weeks |

A dash means I did not find that figure in the sections I read, which is a limit of my reading rather than proof it is absent.

Migraine breaks the mirror model completely. In the pooled PREEMPT analysis published by Dodick and colleagues in Headache in 2010, 1,384 adults were randomized, and the primary endpoint was mean change from baseline in headache-day frequency at week 24: a drop of 8.4 days with onabotulinumtoxinA against 6.6 with placebo. Nobody was checking a mirror on day five. They were counting days across half a year.

A later PREEMPT analysis by Silberstein and colleagues, in The Journal of Headache and Pain in 2013, found that among patients who did not respond to the first cycle, an additional 11.3% to 14.5% became responders after the second, and a further 7.4% to 10.3% after the third. The European Headache Federation's 2018 consensus guideline recommends stopping treatment only if a patient fails across the first two to three cycles.

Read that against a forehead. In one setting four weeks is a complete answer. In the other, nine months of treatment can still be the beginning of one.

Same name, different doses

The timelines differ because the treatments differ underneath the brand. The cosmetic label prescribes 20 Units for glabellar lines, delivered as 4 Units into each of five sites across the two corrugators and the procerus. Lateral canthal lines take 24 Units across six sites. Forehead lines take 20 Units in the frontalis, given together with the 20-Unit glabellar treatment, for 40 Units total. Platysma bands take 26, 31 or 36 Units depending on how the bands present. Chronic migraine takes 155 Units across 31 sites in seven head and neck muscle areas.

The label also states flatly that units of BOTOX Cosmetic cannot be compared to or converted into units of any other botulinum toxin product. Somebody else's forty units of a different brand is not a quantity you can hold against yours.

This is the mistake I made through most of my first year, and it cost me. I fitted by length, because length was the number the customer and I could both see, and treated width as a refinement for fussy cases. A boy came back in September with the vamp of both shoes stretched sideways and a raw patch on the outside of one foot. He had been in a D when he needed an E. The length had been perfect. I refunded the pair out of my own commission, and his mother took her three children elsewhere for four years. I had been reading the printed number instead of the one that governed the outcome.

The four-hour rule, and what one trial actually showed

You have probably been told to stay upright for four hours, not to rub the area, maybe not to exercise. I went looking for the four-hour rule in the BOTOX Cosmetic prescribing information and did not find it. The administration sections cover reconstitution, dose and injection sites. They tell the injector where to put the needle and say nothing about what you do afterward.

That does not make the instruction harmful. It is cheap, the reasoning behind it is plausible, and the thing it guards against is a drooping eyelid. Precaution is legitimate to offer. Calling it evidence is not.

The one controlled test of an aftercare instruction I could find is worth knowing. Alam and colleagues, in the Journal of the American Academy of Dermatology in 2019, ran a randomized crossover trial in which women were assigned either to a prescribed regimen after injection, three sets of forty forehead raises and forty scowls, or to refrain from facial contractions for four hours. Blinded raters scored them at days 1, 2, 3, 4, 7 and 14. The exercise arm scored significantly better by day three, and participants noticed glabellar improvement at days two to three rather than three to four.

Twenty-two women completed it. One site, one crossover, a fortnight of follow-up. What it supports is roughly one day of earlier onset. What it does not support is a better final result, a longer duration, or any claim about how much product reached the right muscle. Speeding up a result you were going to get anyway is a small prize.

Uneven at day six: worth a call, or worth waiting?

Both, in different directions.

For years, when a child's two feet measured differently, I re-measured, because I assumed one of the readings was wrong. Around my sixth year, roughly 2019, I stopped. The re-measure almost always confirmed the difference. About a third of the feet I put on the Brannock came out half a size apart, and none of them were defective. I had been treating the most common finding in my job as an error.

Faces are not feet, and I will not pretend the mechanism transfers. The reasoning error does. At day six, comparing your left brow to your right and concluding you were undertreated is a judgment made before the assessment point, against a body that was already asymmetric.

The trial adverse event rates separate common from rare. In the glabellar line studies, eyelid ptosis occurred in 13 of 405 treated subjects, 3%, against none on placebo, with facial pain, facial paresis and muscular weakness each near 1%. In the forehead line studies, headache occurred in 58 of 665, 9%, against 5% on placebo, with eyelid ptosis 2%, brow ptosis 2% and skin tightness 2%. In the lateral canthal line studies, eyelid edema occurred in 5 of 526, 1%.

Now the part that is not about aesthetics, where I should be straight about what I am. I have never held a syringe, never watched a corrugator injection, and cannot tell you what a drooping lid feels like from the inside. What I can vouch for is nine years of watching people meet a number that describes a population and decide their own body is the thing that is wrong. For what follows I am reading you the label.

The boxed warning on every botulinum toxin product says effects may spread from the injection area to produce symptoms including asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These have been reported hours to weeks after injection, and swallowing and breathing difficulties can be life threatening, with reports of death. Those are not results to assess at Day 30. They are reasons to seek care immediately.

What to take to the follow-up

If you are unsure whether to wait or call, take structure rather than a feeling.

1. Write down the exact product name, indication treated, total units and date, from your treatment record rather than memory.
2. Photograph the area at rest and at full contraction, same distance and lighting, once now and once on your assessment day.
3. Hold the touch-up question until the assessment point matching your indication: Day 30 for frown, forehead and crow's feet lines, Day 14 for platysma bands.
4. Escalate anything on the boxed warning list immediately, in a separate call, without waiting for the follow-up appointment.

Bring the photographs and the units to that appointment. An injector who can see what you looked like on day two and on day thirty is being asked a question they can answer. "It looks weird" is not that question.

Frequently asked questions

What is the 4-hour rule for Botox?

It is the common aftercare instruction to stay upright and avoid rubbing the treated area for about four hours after injection. It does not appear in the BOTOX Cosmetic prescribing information, which covers dose and injection sites only. Clinics give it as a precaution, not as a trial-tested way to improve your result.

What makes Botox kick in faster?

One small randomized crossover trial (Alam and colleagues, Journal of the American Academy of Dermatology, 2019) found that repeated forehead raises and scowls after injection made glabellar improvement visible about a day sooner, at days two to three instead of three to four. Twenty-two women completed it. Nothing showed a better or longer final result.

How long does Botox work on the forehead?

The BOTOX Cosmetic label gives a duration figure for glabellar frown lines only: approximately three to four months. For forehead lines treated in the frontalis muscle, the label states a Day 30 assessment point and a dose of 20 Units, but no duration. Individual results vary, and the label does not promise otherwise.

How long does Botox take to work for muscle spasms?

For blepharospasm, the BOTOX label states the initial effect is generally seen within three days, peaking at one to two weeks. For cervical dystonia, improvement generally begins within the first two weeks, with maximum benefit at approximately six weeks. Repeat treatment for dystonia and spasticity is generally no sooner than 12 weeks.

How long should I wait before asking about uneven Botox results?

Wait for the assessment point matching your treatment: Day 30 for frown, forehead and crow's feet lines, Day 14 for platysma bands. Muscle strength rarely settles at the same rate on both sides. Before that day you are comparing an unfinished result against itself. New drooping is different, and worth a call immediately.

Which symptoms after Botox need urgent medical care?

The boxed warning on every botulinum toxin product names swallowing and breathing difficulties, which can be life threatening, along with muscle weakness, drooping eyelids, double vision, hoarseness, slurred speech and loss of bladder control. These have been reported hours to weeks after injection. Seek care immediately rather than waiting.